(5R)-5-[2-[4-[C-(azetidin-1-yl)-N-hydroxycarbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[4-[N-hydroxy-C-(4-methyl-1,4-diazepan-1-yl)carbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-1,3-dihydroisoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[3-[(Z)-N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[3-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione
C106H108N22O20 — CID 172929585
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5R)-5-[2-[4-[C-(azetidin-1-yl)-N-hydroxycarbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[4-[N-hydroxy-C-(4-methyl-1,4-diazepan-1-yl)carbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-1,3-dihydroisoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[3-[(Z)-N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[3-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione
(5R)-5-[2-[4-[C-(azetidin-1-yl)-N-hydroxycarbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[4-[N-hydroxy-C-(4-methyl-1,4-diazepan-1-yl)carbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-1,3-dihydroisoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[3-[(Z)-N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[3-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione (PubChem CID 172929585) has the molecular formula C106H108N22O20 and a molecular weight of 2010.16 g/mol. Its IUPAC name is (5R)-5-[2-[4-[C-(azetidin-1-yl)-N-hydroxycarbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[4-[N-hydroxy-C-(4-methyl-1,4-diazepan-1-yl)carbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-1,3-dihydroisoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[3-[(Z)-N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[3-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione.
Molecular Properties
| Compound Name | (5R)-5-[2-[4-[C-(azetidin-1-yl)-N-hydroxycarbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[4-[N-hydroxy-C-(4-methyl-1,4-diazepan-1-yl)carbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-1,3-dihydroisoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[3-[(Z)-N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[3-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione |
|---|---|
| PubChem CID | 172929585 |
| Molecular Formula | C106H108N22O20 |
| Molecular Weight | 2010.16 g/mol |
| Exact Mass | 2008.81 |
| IUPAC Name | (5R)-5-[2-[4-[C-(azetidin-1-yl)-N-hydroxycarbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[4-[N-hydroxy-C-(4-methyl-1,4-diazepan-1-yl)carbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-1,3-dihydroisoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[3-[(Z)-N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[3-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)phenyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione |
| SMILES | COc1ccc2c(c1)C(=O)N(C[C@@]1(C#Cc3ccc(C(=NO)N4CCC4)cc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(C#Cc3cccc(/C(=N/O)N4CCN(C)CC4)c3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(C#Cc3cccc(C(=NO)N4CCOCC4)c3)NC(=O)NC1=O)C2.COc1ccc2c(c1)CN(C[C@@]1(C#Cc3ccc(C(=NO)N4CCCN(C)CC4)cc3)NC(=O)NC1=O)C2 |
| InChI | InChI=1S/C28H32N6O4.C27H28N6O5.C26H25N5O6.C25H23N5O5/c1-32-12-3-13-34(15-14-32)25(31-37)21-6-4-20(5-7-21)10-11-28(26(35)29-27(36)30-28)19-33-17-22-8-9-24(38-2)16-23(22)18-33;1-31-10-12-32(13-11-31)23(30-37)19-5-3-4-18(14-19)8-9-27(25(35)28-26(36)29-27)17-33-16-20-6-7-21(38-2)15-22(20)24(33)34;1-36-20-6-5-19-15-31(23(32)21(19)14-20)16-26(24(33)27-25(34)28-26)8-7-17-3-2-4-18(13-17)22(29-35)30-9-11-37-12-10-30;1-35-19-8-7-18-14-30(22(31)20(18)13-19)15-25(23(32)26-24(33)27-25)10-9-16-3-5-17(6-4-16)21(28-34)29-11-2-12-29/h4-9,16,37H,3,12-15,17-19H2,1-2H3,(H2,29,30,35,36);3-7,14-15,37H,10-13,16-17H2,1-2H3,(H2,28,29,35,36);2-6,13-14,35H,9-12,15-16H2,1H3,(H2,27,28,33,34);3-8,13,34H,2,11-12,14-15H2,1H3,(H2,26,27,32,33)/b;30-23-;;/t28-;27-;26-;25-/m1111/s1 |
| InChIKey | CKMNMZZDADHBKP-STFLXSSSSA-N |
| XLogP | 3.95 |
| TPSA | 492.92 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 148 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2010.16 |
| LogP ≤ 5 | 3.95 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 27 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'hydantoin', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'oxime_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 172929585 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.